Cynapsus Therapeutics Company

Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson–≤–Р–©s disease.
Technology: Biologics
Industry: PharmTech
Headquarters: Canada
Founded Date: 2004
Employees Number: 11-50
Funding Status: M&A
Investors Number: 3
Total Funding: $23.8M
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership